Friday, February 3, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
  • Purchase DME
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
  • Purchase DME
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Uncertainty & Complexity

Vaping: A Tale of Two Crises

Jay K Joshi by Jay K Joshi
July 13, 2022
in Uncertainty & Complexity
0
Vaping: A Tale of Two Crises

Close-up of a young woman exhaling smoke vapour from an electronic cigarette, holding the device in her hand. Shot at home, indoors.

“This has turned into a healthcare crisis”, Congressman Joseph Kennedy III (D-MA) said in 2019, referring to the then nascent vaping crisis.

It emerged out of an attempt to create a new smoking cessation option, but spawned its own set of addictive behaviors, particularly among adolescents. Or so we believed. Vaping, or e-cigarettes, which consist of a vaporizer and a liquid cartridge with a liquid nicotine solution, were initially touted as a safe alternative to cigarettes, and spunky startups arose evangelizing public safety, in their entrepreneurial zeal to bring these products to market. Soon the cartridges added various flavors to go along with the nicotine. Some contained marijuana. After a few short years on the market, there were over 400 flavors, and vaping became so popular among college students that use doubled from 2017 to 2018. That same year, 20 percent of Americans aged 18 or younger had used e-cigarettes in some capacity.

But by 2019, people were developing mysterious lung injuries severe enough to result in hospitalizations and even deaths. The New England Journal of Medicine called teen vaping an epidemic, and the CDC studied the cartridges to see what was causing these symptoms. Public policy experts and law enforcement went on the offensive, putting restrictions on what vaping flavors people could buy and where vaping could be done. Vaping drug busts made headlines, as highly publicized raids by local and federal law enforcement officers confiscated increasingly large amounts of illicit cartridges.

Yet high schoolers continued vaping, and in greater numbers. Surveys found that nearly one in four underaged Americans were vaping. Schools across the country joined the frontline offensive against the vaping crisis and increased drug testing in schools. Some began drug testing every student over the course of an academic year. Yet despite the increased restrictions, and increased publicity of the health risks, more teens continued to vape, resulting in more hospitalizations and more deaths.

Healthcare researchers struggled to make sense of it all. Sixty percent of vaping-related deaths involved only nicotine cartridges, but 80 percent of lung injuries requiring hospitalizations involved cartridges with both nicotine and THC. The median age of use was 23, but the median age of death was 53. And 80 percent of lung injuries came from users aged 35 or younger.

Although the data presented unfamiliar patterns of complications, lawmakers followed a familiar pattern of reacting with heightened restrictions and criminal investigations. High-profile investigations of vaping companies began, similarly targeting their marketing tactics. These were similarly reinterpreted to be aggressive and deceptive, as an attempt to create addictions among users. Everyone seemed to forget that the original intention of vaping had been to address cigarette addiction.

Vaping companies soon pushed back, demonstrating the value their product provides when used appropriately. When the state of Massachusetts instituted a statewide ban on vaping, the Vaping Technology Association fought the ban and began conducting research, demonstrating the value of vaping for patients struggling with nicotine addiction.

By resisting and changing the conversation from criminal behavior to clinical research, the vaping industry showed the benefits when used responsibly among certain users, emphasizing that the context around the behavior determines the clinical benefits or harms more than just the act of vaping.

Dr. Rachel King, Director of Addiction Psychology at Cornell, studied vaping as a viable treatment option for nicotine addiction, and found a relationship between vaping and cigarettes. In coupling vaping with cigarette smoking, she noted that by restricting one you promote the other, and vice versa. She then discovered that the vaping epidemic is really two separate epidemics: one affecting older users who use traditional nicotine cartridges, and one affecting younger users who combine nicotine and THC cartridges. Older users suffer from lung injuries due to lipid-based molecules in the cartridges, while younger users had lung injuries arise from combining THC and nicotine.

Although the act of vaping may be the same, the health risks are different. By studying the behavior around vaping – the context of use – Dr. King saw two patterns of behavior, and two health risks for two distinct user groups. She concluded that vaping is best used in a balance with traditional cigarette smoking. Instead of aggressively targeting vaping, consequently shifting use back to traditional cigarettes, we should seek a balance that limits the high-risk aspects of vaping while supporting its positive aspects in curtailing cigarette addictions.

This explains why the Department of Health and Human Services opted for a targeted ban on specific flavors of vaping cartridges, while permitting traditional flavors like menthol, which are more commonly used among those quitting cigarettes. The targeted restrictions acknowledge the risks in both vaping and cigarettes, but also recognize that a balance can encourage patients to use vaping to combat cigarette addiction, its original intended use.

Does that imply that we could have saved lives by preemptively educating the public on safe vaping practices? The answer hinges on a series of perceptions: (1) whether you see vaping as a tool for smoking cessation or for drug abuse, (2) whether you believe in the benefits of drug education, and (3) whether you see drug education as an implicit moral hazard against drug addiction. The number of perspectives through which we can view this question is larger than we would have initially thought. But we focus on one perception, and given it all of our attention and focus, while burying all other perspectives, and along the way, simplifying clinical complexity in favor of the prevailing narrative.

Something the FDA is guilty of.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

YouTube Video VVUxUDVQenU5RTFjUVFKNDY2ZlBmdFB3LmdVUm55WVpqRmNn This is a video about Elemental/Essential Frameworks of Healthcare Law

00:00 Elemental/Essential Frameworks of Healthcare Law
Load More... Subscribe

Expert vs. Lay Testimony

Visuals

NADAC (National Average Drug Acquisition Cost)

NADAC (National Average Drug Acquisition Cost)

by Jay K Joshi
January 29, 2023
0

We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much does the government pay for common drugs utilized by patients on Medicaid. Drugs listed are from A-CH.  

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • Malicious Prosecution and Fabrication of Evidence

    Malicious Prosecution and Fabrication of Evidence

    0 shares
    Share 0 Tweet 0
  • 2022 Letter to the American Medical Association

    0 shares
    Share 0 Tweet 0
  • 2023 Letter to the American Medical Association

    0 shares
    Share 0 Tweet 0
  • Letter to the Alabama Board of Medical Examiners

    0 shares
    Share 0 Tweet 0
  • Prosecuting Doctors as Drug Dealers

    0 shares
    Share 0 Tweet 0

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
    • Contrarian
    • Financial Markets
    • Innovations & Investing
    • Perspectives
    • Politics & Law
    • Trends
    • Uncertainty & Complexity
  • Podcasts
  • Surveys
    • Survey Results
  • About Us
  • Contact us
  • Support Us

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do